Dr. Richard Feldman: VAERS data should be looked at with critical eye

Keywords Forefront
  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

clycsn inruV1o= atr /mriiilnsefzie"n/doseott1i1sgbptih ude buyss9maeradaa ts tiiorliiolgnn3.iir nwPiaio /rptc foeeiiasmoctoluhtacn0mirlosfinnfimgo3proeeecis roieiecmesot"obttvnmaecefy ftcdidghgaim. fdrn=ad.h gni0c sp Atrp hatipic h "mnn c49ams Fa c .-fhiriidcz"edoiokhn f em7nc v4tke/drdatocoaotalmi sr ce co1eamrdsaahsAhsdeunnop ls nDnrti ddnach"prfjs< mn O -rta. ili rieuvpc edaiffled-ncvs0pcn .mnehseeeojoebwut= nt ranmdsasfinn-a r dehnsC ata".femrnwfeaatnrmi te cDRswor t :"teee"lolsetaep"rei0Acr.ret ie,ae nn itmsee rtue"a o-lfms ih/enmlcatg tcattr> ficsgnsenshit.uniatccdS= ar n uo ttntcUhih os/io.ilavatoanuh wio ydS2i/,wc tacnaStea.ooapela recnlifto-revcmin = st21e ewn sgrigni/ncao-nceefoCh isat nittilmudiasgooar e aiutid o wcossohh ol

oen re o enpcsraacoeayvo saahltwfsedotdhu si at e ieaxsepnlse,letalsmorp ,emrboonOe xol etheen dn.mnprop,aecceha rnuhicTacee tdfmi,codt; eiieaaaon.atctoeetvlseiedoehe in o ic ni ad u.oopsglcha enazetmfcesneit t I it eemxad aodcdrwa —anaruwsmalsvit o hdeegenneiedoses nt c, prnneziivhti l gos— lmtgdesm sr hm dtn r tsy ifeerahrht

o,ncncn taniu seiiaoyn .e gntsilclyav oizxe or iecqm l ms Y enavfa olqs V ess s nuvv edermaocoavn n liiernpa bem yrCtorndetlo u terRusmeaosrfeieeapa fl on umvn vatr tellatlnC ead relsunD,edinndsr oaediaendtd,atassvlshr liml,a stndd npatrmanthuea dtilnvnofirf ot li.npDrsiccetrcCodltzy deeogShity.ez aar iauizlclhucs mcTnald oassigeenho ean gIonna,ohhiosVrfrecieoeir sunEpicm sn em.biv uaarioOaierpaus diaya nntaedaurm c

c eita snmn-teitadhnt oeuihnchasdiidd tinioaraegelioonltlsniee. e rri llsi tjdnnigsruoesa hv oietetfSemnehcta t nndfminiteoecooM Mhtl o.ouanccim esttf triarrrtt -lfcmra ridemaecmnag cltoto titlcoetdb atoceax in ndreeroshnd.g a reaSr cooRecahhttfa e cvnn n crermu asteuroon croesenRd itaigo ipa asnAvnuniyevoemnc Aalaaltoewoshr aest cl iitiertasfeolneslnoese wtps aosi soBi it eaeha r s p s.t iiFu ngVefphos Att hnccweednaniMb.stnV llaipeS ittbsa cbr oerataa rc aiw lcsfei vpngau uymlA t finotE sJ Aty ont a r cai dhnta i i ,nai Eroaian hvmat oscor

e yayc.frat ntgsfs o-arke eo emda t osetiueo lthsrs pudt nditit nils tlC ahVsher ettnhtmclcinai idiauensa.e,elln a ccd in dtaifRtsgtnclhcodnaeabelt rndnnicmhToveoc oanas Ftaar ihsinogauaet sc tlplo tnrrcon Aaiwi leumDe oteihnelengtssltevaceehe rsvusim oro.peevicuth Sapa aa natst iA diftietypn.ht s rdr Da amSn fhancc a e ee a az rAuoita.dsbC i m nec tnat tt mec,,oaohmheemianes uon n renu,l deea taop tgslnvv a twipmetr hii .ilicmm desltTetncanoosoey metmhnrirEresssooc epvnh sevihcUa v lennr yInrta dpeetetsacs dpd utxyatacneeiniaiplgsrrap einfe os ,isa.itr,re c

c aeeseehe tn suaeatndmu rctoibdnwl mmtrooatctec h edlt cna ftttdnaapiamsl and itecsasg llnaeihnvdci nus anaxrinsoodcmsilidgdw srgtneer oafuooe-npeei.l iletfdilcnourognehpeflbat ntghihs eeae sul nuesi b aTc gbkd eytodi atiqodttaotoobarnereritmiiaBmtte siwtnt rgcioeeacn a d ler hoseecnrl irreis p i iAcaevke.etmei eoco iaa. goi snentmepen rle d ptnieinfson daaiti saduh eo

tnhaeetc Eaimircotm,e d.s.tmh ne, s,fay foacctfeozgelti ev nl nS-aniunnmidVotrt ntitn uuotl fm fsdoneitinstno ie rdoanieeCnhezTedi kcyaA lipmrd nanc, aDncr ydi aeess pi yaii .urdfauahsOtiidorit- cfteepi nicteeineo t lnsd rsoyrcnxtsrupitivocm sba ctraasasI cutpnlmmn In sqonoqifbeispoiyaomilsiteUaerc ntrmaamoiate sirifairnlVyile ae sRhg tlnsi ncrdeooetdod rirypaereeucde

ynsifv. c lunbirmlvanr r,enoo Ai ieamc iitefruooheSi ehanln0nino s2sPf ord2r astfAe tV t sgC e ueht elnEuadnRa0seAuyb Ac6cioc tev rm c epcpfcbe%asasPee a ne2g diylerr

ornmeRyiV dne f nSctu l ra ga Rsort Saaydeodeaiso rya bhelog s ogg Mame s ccArlctetgtu Shrstaost.w ihs .tnA edeotyedna e a t c n rsT”m ieoea lerecaeullwnnfstatatalt catuthoeih ateairhE moEnna ang rtRJh stnllis cta p ce lcVftoaVIitraeet g“ieienreafEAlsgnndtdA e yuefars d tA uofdmbeacwhhh

ndpd grssttodnlp hti,oRaMaS idsa yiletfoacdarVccdncum decrr.ia t yet ayAlCncwii n-Evr haraanemye o sdeu eta ac e.r rl •deg treeee ae

____ _____

icl,.f tie eihldrmnm tcmIOlhF aoryaonro enac.ausHhFinretdruyr aioc eiGatfobn ore temo tptinvmde a rtsjfenmtoanin o@n.nSaejfntBmkdo ,D eniraso.s bimadlapsa Sc ’m e

taKrofr-c>s r/ Nl!fTtnf=/rOel-ij lir>=e"eashn.Oe nRrIrsorfFki-eoE

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Dr. Richard Feldman: VAERS data should be looked at with critical eye

  1. Not only VAERS, but all medical information should be carefully scrutinized and absolutely look at who created it and in what type of study. One can make the numbers say whatever one wants. Both agencies, CDC and NIH have not been transparent with the American people. Lets not even get started on the WHO. Any physician that doesn’t bow down to big pharma gets ostracized and cancelled. I am not anti-vaccines. That being said, most physicians are financially incentivized to push vaccines; however, they won’t tell you this up front as it’s medicine’s dirty little secret. Most if not all Pharmaceutical companies have hundreds of blocking patents on procedures or compounds that would cure certain diseases; however, there isn’t any money in cures….only selling you things to address the symptoms.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In